TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
RexCell Tissue & Airlaid AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,308,075
|
1,459,383
|
1,305,294 |
| Financial expenses |
803
|
826
|
502 |
| Earnings before taxes |
295,819
|
420,296
|
238,477 |
| EBITDA |
309,026
|
436,544
|
267,455 |
| Total assets |
618,664
|
601,525
|
670,928 |
| Current assets |
315,126
|
325,737
|
400,369 |
| Current liabilities |
241,484
|
225,773
|
284,355 |
| Equity capital |
313,813
|
312,124
|
321,508 |
| - share capital |
1,200
|
1,200
|
1,200 |
| Employees (average) |
196
|
200
|
194 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
50.7%
|
51.9%
|
47.9% |
| Turnover per employee |
6,674
|
7,297
|
6,728 |
| Profit as a percentage of turnover |
22.6%
|
28.8%
|
18.3% |
| Return on assets (ROA) |
47.9%
|
70.0%
|
35.6% |
| Current ratio |
130.5%
|
144.3%
|
140.8% |
| Return on equity (ROE) |
94.3%
|
134.7%
|
74.2% |
| Change turnover |
-151,308
|
154,089
|
469,508 |
| Change turnover % |
-10%
|
12%
|
56% |
| Chg. No. of employees |
-4
|
6
|
4 |
| Chg. No. of employees % |
-2%
|
3%
|
2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.